CARCINOMA, NON-SMALL CELL LUNG CANCER (NSCLC)
Clinical trials for CARCINOMA, NON-SMALL CELL LUNG CANCER (NSCLC) explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, NON-SMALL CELL LUNG CANCER (NSCLC) trials appear
Sign up with your email to follow new studies for CARCINOMA, NON-SMALL CELL LUNG CANCER (NSCLC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug wafer aims to block lung Cancer's return
Disease control Recruiting nowThis study is testing a new drug called SMS001, which is a special form of the chemotherapy paclitaxel. It is being given to patients with early-stage non-small cell lung cancer right after their surgery, with the goal of preventing the cancer from coming back. Researchers will c…
Matched conditions: CARCINOMA, NON-SMALL CELL LUNG CANCER (NSCLC)
Phase: PHASE2 • Sponsor: ToLymph Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
New hope for 'Uncuttable' lung tumors: drug combo aims to enable surgery
Disease control Recruiting nowThis study is testing whether a new drug called IBI363, combined with standard chemotherapy, can shrink stage 3 non-small cell lung cancer that is currently too advanced or complex to remove with surgery. The goal is to shrink the tumors enough so that surgery becomes a safe and …
Matched conditions: CARCINOMA, NON-SMALL CELL LUNG CANCER (NSCLC)
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC